slides · global inventory
Problem Statement Canvas
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,665
Current window 1,981-2,010
Pages 89
Rows per page 30
Tool
1,981-2,010 of 2,665
23
Includes survival curves, immunohistochemistry images, genetic association data, and clinical trial data for atopic dermatitis.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
04
Uses a process diagram to show the 'loop' of optimization (affinity, developability, toxicity) leading to suboptimal outcomes.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
Includes a medical illustration of brain pathways related to wakefulness and neurotransmitters.Alkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
33
Apollo Global Management | Investor Day Presentation Deck | 119 slidesApollo Global Management | Investor Day Presentation Deck | 119 slides · Apollo Global Management
Conference presentation Investor relations Beat · Evidence & Proof1 hit
04
The slide uses a column-based layout with icons and supporting text to present company strengths.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
07
The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to diagnosed to treated.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a clear two-column layout to contrast clinical definitions with market prevalence data.Dare Bioscience | Results Presentation Deck | 14 slides · Daré Bioscience
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem in drug development.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
30
Includes a biological process diagram and a gene expression heatmap.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
15
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needsLoop · Cost Of Inaction1 hit
37
The slide uses a stacked bar chart to show mutation incidence and a comparison table to contrast clinical outcomes across different indications.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
28
Eutelsat | Investor Presentation Deck | 63 slidesEutelsat | Investor Presentation Deck | 63 slides · Eutelsat Group
Conference presentation Investor relations Beat · Solution1 hit
07
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
22
The slide uses a hierarchical clustering heatmap (dendrograms on top and left) to visualize drug sensitivity across 80 small molecules.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations 1 hit
17
The chart compares cross-trial data; the footnote explicitly warns against direct comparison due to protocol differences.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
03
Uses screenshots of competitor products with red circles highlighting disclaimers that they do not check for heart attacks.HeartBeam | Investor Presentation Deck | 18 slides · HeartBeam
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Uses a binary choice framework to highlight the negative outcomes of patient uncertainty.HeartBeam | Investor Presentation Deck | 18 slides · HeartBeam
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
This is a classic 'problem-solution' framing slide.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Uses a hub-and-spoke diagram to illustrate the negative impacts of a central problem.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
53
Includes multiple citations and diagrams illustrating the mechanism of action and clinical efficacy.Immix Biopharma | Investor Presentation Deck | 61 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
51
The slide uses a bubble chart to map clinical trial outcomes and a table to detail specific drug performance metrics across treatment lines.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
07
Includes a cartoon illustration of a cell/virus character.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
46
The bubble chart maps mPFS against patient treatment history; the table highlights poor outcomes and high toxicity across lines of therapy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
11
Uses a visual timeline/process flow to explain the biological progression of CRC.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
03
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · Problem1 hit
04
Nemaura Medical | Investor Presentation Deck | 29 slidesNemaura Medical | Investor Presentation Deck | 29 slides · Nemaura Medical
Conference presentation Investor relations Beat · Problem1 hit
07
Uses a visual process flow to contrast standard therapy failure with Nuvalent's mechanism.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit